Cogent Biosciences, Inc. (COGT)

37.34 -1.00 (-2.61%) USD  |  NASDAQ  |  Feb 20, 16:00
37.56 +0.22 (+0.59%) After-Hours: 20:00
More

Cogent Biosciences Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade